Cañales, Renelia .

HRN: 01-62-87  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2023
CEFTAZIDIME 1GM (VIAL)
01/03/2023
01/09/2023
IV
1g
Q8
CAP-MR, T/C PTB Relapse
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: